7Roehrbohn CG, McConnell JD, Bonilla J, et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia: PLESS study. J Urol, 2000, 163:13-20.
8Hutchison A, Farmer R, Verhamme K, et al. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Eur Urol,2007, 51:207-215.
9Djavan B, Nickel JC, de la Rosette J, et al. The urologist view of BPH progression:results of an international questionnaires. Eur Urol, 2002, 41:490-496.
10Roehrborn CG, McConnell JD. Etiology, pathothysiology, epidemiology and natural history of binign prostatic hyperplasia// Walsh PC, Retik AB, Vaughan ED, et al. Campbell' s Urology. Philadelphia : WB Saunders Company, 2002 : 1297-1330.
3Muzzonigro G,Milanese G,Minardi D,et al.Safety and efficacy of transurethral resection of prostate glands up to 150 ml:a prospective comparative study with 1 year of followup[J].J Urol.2004,172:611-615.
4Soh BH,Kim JH,Han WK,et al.safety of transurethral resection of the prostate in markedly enlarged (> 100gin) prostate[J].J Uro1,2008,179 suppl:672-673.
5Bushman W.Etiology,epidemiolog,and natural history of benignprostatic hyperplasia[J].Uml Clin North Am,2009,36(4):403-415.
6Fibbi B,Penna G,Morelli A,et al.Chronic inflammation in thepathogenesis of benign prostatic hyperplasia[J].Int J Androl,2009,32(8):l-15.
